Abstract: The present invention relates to a method of culturing a pancreatic progenitor cell. The method comprises contacting the cell with epidermal growth factor (EGF), retinoic acid (RA) and an inhibitor of transforming growth factor-? (TGF-?) and 3T3-J2 feeder cells. A cell produced by the method of the invention and a kit when used in the method are also provided.
Type:
Application
Filed:
January 17, 2018
Publication date:
May 7, 2020
Applicant:
Agency for Science, Research and Technology
Abstract: A method of reducing aggregate content in a preparation having a target protein includes contacting the preparation with an alkyl cation to form a mixture, and contacting the mixture with at least one functionalized solid to remove excess alkyl cation.
Type:
Grant
Filed:
February 27, 2014
Date of Patent:
July 17, 2018
Assignee:
AGENCY FOR SCIENCE, RESEARCH AND TECHNOLOGY
Abstract: We describe an Fve polypeptide being a fragment, homologue, variant or derivative of Fve protein, which comprises at least one biological activity of Fve protein. uses of such a polypeptide, etc, and nucleic acids encoding these, in the treatment and prevention of allergy and cancer are also disclosed.
Type:
Grant
Filed:
June 30, 2011
Date of Patent:
January 8, 2013
Assignees:
National University of Singapore, Agency for Science and Research
Inventors:
Kaw Yan Chua, See Voon Seow, Prasanna Ratnakar Kolatkar